These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 21839368

  • 1. Primary IgA nephropathy: new insights into pathogenesis.
    Barratt J, Feehally J.
    Semin Nephrol; 2011 Jul; 31(4):349-60. PubMed ID: 21839368
    [Abstract] [Full Text] [Related]

  • 2. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 3. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC.
    Nefrologia; 2005 Jun; 25 Suppl 2():82-6. PubMed ID: 16050408
    [Abstract] [Full Text] [Related]

  • 4. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?
    Floege J.
    Am J Kidney Dis; 2011 Dec; 58(6):992-1004. PubMed ID: 21872377
    [Abstract] [Full Text] [Related]

  • 5. [Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].
    Segarra A.
    Nefrologia; 2010 Dec; 30(5):501-7. PubMed ID: 20882091
    [Abstract] [Full Text] [Related]

  • 6. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
    Xie L, Wang L, Huang J, Fan J.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):227-30. PubMed ID: 20337060
    [Abstract] [Full Text] [Related]

  • 7. [Pathogenesis of Berger's disease: recent advances on the involvement of immunoglobulin A and their receptors].
    Monteiro RC, Leroy V, Launay P, Moura IC, Arcos-Fajardo M, Benhamou M, Haddad E.
    Med Sci (Paris); 2003 Dec; 19(12):1233-41. PubMed ID: 14691748
    [Abstract] [Full Text] [Related]

  • 8. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 9. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Dec; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 10. Role of podocyte injury in IgA nephropathy.
    Menon MC, Chuang PY, He JC.
    Contrib Nephrol; 2013 Dec; 181():41-51. PubMed ID: 23689566
    [Abstract] [Full Text] [Related]

  • 11. The glomerular response to IgA deposition in IgA nephropathy.
    Moura IC, Benhamou M, Launay P, Vrtovsnik F, Blank U, Monteiro RC.
    Semin Nephrol; 2008 Jan; 28(1):88-95. PubMed ID: 18222350
    [Abstract] [Full Text] [Related]

  • 12. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
    Novak J, Barratt J, Julian BA, Renfrow MB.
    Semin Nephrol; 2018 Sep; 38(5):461-476. PubMed ID: 30177018
    [Abstract] [Full Text] [Related]

  • 13. [Immunoglobulin A (IgA) and its cellular receptors: Recent advances and new pathogenetical hypothesis].
    Amore A, Monteiro R, Coppo R.
    G Ital Nefrol; 2006 Sep; 23(3):313-22. PubMed ID: 16868911
    [Abstract] [Full Text] [Related]

  • 14. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Sep; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 15. Role of IgA receptors in the pathogenesis of IgA nephropathy.
    Lechner SM, Papista C, Chemouny JM, Berthelot L, Monteiro RC.
    J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
    [Abstract] [Full Text] [Related]

  • 16. [New immunopathogenic aspects of IgA nephropathy].
    Hernando L, González-Cabrero J, García-Hoyo R, Hernando P, Egido J.
    Bull Acad Natl Med; 1990 May; 174(5):549-59. PubMed ID: 2249143
    [Abstract] [Full Text] [Related]

  • 17. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

  • 18. IgA-CD89 complex in IgA nephropathy: a study on molecular function.
    Wiwanitkit V.
    Ren Fail; 2006 Sep; 28(6):457-9. PubMed ID: 16928613
    [Abstract] [Full Text] [Related]

  • 19. Pathogenesis of IgA nephropathy.
    Lai KN.
    Nat Rev Nephrol; 2012 Mar 20; 8(5):275-83. PubMed ID: 22430056
    [Abstract] [Full Text] [Related]

  • 20. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.
    Tamouza H, Chemouny JM, Raskova Kafkova L, Berthelot L, Flamant M, Demion M, Mesnard L, Paubelle E, Walker F, Julian BA, Tissandié E, Tiwari MK, Camara NO, Vrtovsnik F, Benhamou M, Novak J, Monteiro RC, Moura IC.
    Kidney Int; 2012 Dec 20; 82(12):1284-96. PubMed ID: 22951891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.